[go: up one dir, main page]

WO2006038980A3 - Articles non absorbants et absorbants inhibant la production d'exoproteines - Google Patents

Articles non absorbants et absorbants inhibant la production d'exoproteines Download PDF

Info

Publication number
WO2006038980A3
WO2006038980A3 PCT/US2005/028366 US2005028366W WO2006038980A3 WO 2006038980 A3 WO2006038980 A3 WO 2006038980A3 US 2005028366 W US2005028366 W US 2005028366W WO 2006038980 A3 WO2006038980 A3 WO 2006038980A3
Authority
WO
WIPO (PCT)
Prior art keywords
absorbent
substituted
amino acid
group
exoproteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/028366
Other languages
English (en)
Other versions
WO2006038980A2 (fr
Inventor
Rae Ellen Syverson
Kristin A Goerg-Wood
Daniel J Devine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kimberly Clark Worldwide Inc
Kimberly Clark Corp
Original Assignee
Kimberly Clark Worldwide Inc
Kimberly Clark Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/955,858 external-priority patent/US20060067991A1/en
Priority claimed from US10/955,821 external-priority patent/US20060067990A1/en
Application filed by Kimberly Clark Worldwide Inc, Kimberly Clark Corp filed Critical Kimberly Clark Worldwide Inc
Priority to BRPI0515949-0A priority Critical patent/BRPI0515949A/pt
Priority to AU2005292655A priority patent/AU2005292655A1/en
Priority to JP2007534582A priority patent/JP2008514698A/ja
Priority to EP05785615A priority patent/EP1793871A2/fr
Publication of WO2006038980A2 publication Critical patent/WO2006038980A2/fr
Publication of WO2006038980A3 publication Critical patent/WO2006038980A3/fr
Priority to IL181198A priority patent/IL181198A0/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/214—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention concerne des articles non absorbants et absorbants destinés à inhiber la production d'exoprotéines provenant de bactéries Gram positif. Lesdits articles comprennent une quantité efficace d'un composé précurseur représenté par la formule générale (I). Dans la formule, R1 est sélectionné dans le groupe constitué par les formules (II) et (III); R7 représente -OCH2-; X égale 0 ou 1; R5 représente un noyau aromatique substitué ou non substitué ou une fraction hydrocarbyle monovalente, saturée ou insaturée, substituée ou non substituée, ramifiée ou à chaîne droite, pouvant éventuellement être substituée par des hétéroatomes; R6 est sélectionné dans le groupe constitué par un acide aminé, un ester méthylique d'acide aminé et un ester éthylique d'acide aminé; R2, R3 et R4 sont sélectionnés indépendamment dans le groupe constitué par H, OH, COOH.
PCT/US2005/028366 2004-09-30 2005-08-10 Articles non absorbants et absorbants inhibant la production d'exoproteines Ceased WO2006038980A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BRPI0515949-0A BRPI0515949A (pt) 2004-09-30 2005-08-10 artigos não-absorventes e absorventes para inibir a produção de exoproteìnas
AU2005292655A AU2005292655A1 (en) 2004-09-30 2005-08-10 Non-absorbent and absorbent articles for inhibiting the production of exoproteins
JP2007534582A JP2008514698A (ja) 2004-09-30 2005-08-10 外来蛋白質の生成を阻害するための非吸収性物品及び吸収性物品
EP05785615A EP1793871A2 (fr) 2004-09-30 2005-08-10 Articles non absorbants et absorbants inhibant la production d'exoproteines
IL181198A IL181198A0 (en) 2004-09-30 2007-02-07 Non-absorbent and absorbent articles for inhibiting the production of exoproteins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/955,858 US20060067991A1 (en) 2004-09-30 2004-09-30 Non-absorbent articles for inhibiting the production of exoproteins
US10/955,821 US20060067990A1 (en) 2004-09-30 2004-09-30 Absorbent articles for inhibiting the production of exoproteins
US10/955,858 2004-09-30
US10/955,821 2004-09-30

Publications (2)

Publication Number Publication Date
WO2006038980A2 WO2006038980A2 (fr) 2006-04-13
WO2006038980A3 true WO2006038980A3 (fr) 2006-06-29

Family

ID=36066376

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/028366 Ceased WO2006038980A2 (fr) 2004-09-30 2005-08-10 Articles non absorbants et absorbants inhibant la production d'exoproteines

Country Status (8)

Country Link
EP (1) EP1793871A2 (fr)
JP (1) JP2008514698A (fr)
KR (1) KR20070057884A (fr)
AU (1) AU2005292655A1 (fr)
BR (1) BRPI0515949A (fr)
IL (1) IL181198A0 (fr)
RU (1) RU2007111692A (fr)
WO (1) WO2006038980A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100130907A1 (en) * 2008-11-21 2010-05-27 Linkel Stephan M Article of manufacture used in contact with human body surfaces

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB745607A (en) * 1952-12-09 1956-02-29 Geigy Ag J R Improvements relating to antiseptic, bactericidal, or the like agents for disinfection
GB830139A (en) * 1954-12-29 1960-03-09 George Van Norden Morin Fabrics containing bactericidal agents
US3027301A (en) * 1959-03-16 1962-03-27 Us Vitamin Pharm Corp Therapeutic wound healing composition of hydroxypropylamides of hydroxybenzoic acids
US4431427A (en) * 1981-10-05 1984-02-14 University Of Delaware Tampons and their manufacture
US4725590A (en) * 1983-08-24 1988-02-16 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
US6245786B1 (en) * 1995-11-22 2001-06-12 Allergan Sales, Inc. Substituted aryl or heteroarylamides having retinoid-like biological activity
US20030165559A1 (en) * 2001-11-21 2003-09-04 Kimberly-Clark Worldwide, Inc. Non-absorbent articles containing additives
US6676957B1 (en) * 2000-11-28 2004-01-13 Kimberly-Clark Worldwide, Inc. Non-absorbent substrates for the inhibition of exoprotein production from gram positive bacteria

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB745607A (en) * 1952-12-09 1956-02-29 Geigy Ag J R Improvements relating to antiseptic, bactericidal, or the like agents for disinfection
GB830139A (en) * 1954-12-29 1960-03-09 George Van Norden Morin Fabrics containing bactericidal agents
US3027301A (en) * 1959-03-16 1962-03-27 Us Vitamin Pharm Corp Therapeutic wound healing composition of hydroxypropylamides of hydroxybenzoic acids
US4431427A (en) * 1981-10-05 1984-02-14 University Of Delaware Tampons and their manufacture
US4725590A (en) * 1983-08-24 1988-02-16 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
US6245786B1 (en) * 1995-11-22 2001-06-12 Allergan Sales, Inc. Substituted aryl or heteroarylamides having retinoid-like biological activity
US6676957B1 (en) * 2000-11-28 2004-01-13 Kimberly-Clark Worldwide, Inc. Non-absorbent substrates for the inhibition of exoprotein production from gram positive bacteria
US20030165559A1 (en) * 2001-11-21 2003-09-04 Kimberly-Clark Worldwide, Inc. Non-absorbent articles containing additives

Also Published As

Publication number Publication date
JP2008514698A (ja) 2008-05-08
WO2006038980A2 (fr) 2006-04-13
RU2007111692A (ru) 2008-11-10
EP1793871A2 (fr) 2007-06-13
KR20070057884A (ko) 2007-06-07
AU2005292655A1 (en) 2006-04-13
IL181198A0 (en) 2007-07-04
BRPI0515949A (pt) 2008-08-12

Similar Documents

Publication Publication Date Title
AU2003222450A1 (en) Stabilized ascorbic acid derivatives
EP1403255A4 (fr) Inhibiteurs de rho kinase
WO2002000679A3 (fr) Composes organiques
CA2424600A1 (fr) Composes aliphatiques azotes a noyau a cinq elements
CA2150287A1 (fr) Agent therapeutique pour les affections hepatobiliaires
NZ598172A (en) Synthesis of boronic ester and acid compounds
MXPA02012875A (es) Derivado de benzoilpiridina o su sal, fungicida que lo contiene como un ingrediente activo, su procedimiento de produccion e intermediario para producirlo.
GB0403864D0 (en) Modulator
IL148968A0 (en) Neutral-cationic lipid for nucleic acid and drug delivery
UA89672C2 (en) Sulfonylamino(thio)carbonyl compounds
WO2007135466A3 (fr) Lactones n-acyle homosérine substituées
IL153352A0 (en) Coumarin derivatives with comt inhibiting activity
CA2475648A1 (fr) Lentille en matiere plastique et procede pour sa preparation
CA2306963A1 (fr) Nouveaux 3,6-hemicetals appartenant a la classe des 9a-azalides
BG107050A (en) Method for the preparation of citalopram
TWI339659B (en) Aqueous composition comprising thiazole derivative
WO2006038980A3 (fr) Articles non absorbants et absorbants inhibant la production d'exoproteines
WO2008090717A1 (fr) Inhibiteur de l'adam
WO2007033039A3 (fr) Composes de beta lactam inhibant le proteasome
WO2002059089A3 (fr) Procede de preparation d'analogues d'indene heterocycliques
CA2309485A1 (fr) Nouveaux derives de 4-arylpiperidine pour le traitement du prurit
MXPA04002474A (es) Inhibicion de produccion de exoproteina usando composiciones aromaticas.
CO5080739A1 (es) Compuestos antibacterianos de cefalosporinas de 7-acilamino- 3-(amino-guanidina ciclica) metileno utiles como productos farmaceuticos y procesos para su produccion
WO2002050081A3 (fr) Agents antimicrobiens
WO2001052824A3 (fr) Utilisation de composes speciaux pour la prophylaxie et la therapie de l'hepatite c

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 181198

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2005292655

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2005292655

Country of ref document: AU

Date of ref document: 20050810

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005292655

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 200580032433.4

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: MX/a/2007/003706

Country of ref document: MX

Ref document number: 2007534582

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1020077007186

Country of ref document: KR

Ref document number: 1313/CHENP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2005785615

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007111692

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2005785615

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0515949

Country of ref document: BR